P/E ratio for Array Technologies (ARRY)

P/E ratio history for Array Technologies from 2020 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Amgen AMGN	18.6	56.14%	🇺🇸 USA
Onconova Therapeutics ONTX	-0.9953	-108.38%	🇺🇸 USA
Novartis NVS	26.2	120.89%	🇨🇭 Switzerland
Eli Lilly LLY	144	1,112.46%	🇺🇸 USA
AstraZeneca AZN	33.3	180.56%	🇬🇧 UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.